3-O-Methylfunicone, a Selective Inhibitor of Mammalian Y-Family DNA Polymerases from an Australian Sea Salt Fungal Strain
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
We isolated a pol inhibitor from the cultured mycelia extract of a fungal strain isolated from natural salt from a sea salt pan in Australia, which was identified as 3-O-methylfunicone by spectroscopic analyses. This compound selectively inhibited the activities of mammalian Y-family DNA polymerases (pols) (i.e., pols η, ι and κ). Among these pols, human pol κ activity was most strongly inhibited, with an IC50 value of 12.5 μM. On the other hand, the compound barely influenced the activities of the other families of mammalian pols, such as A-family (i.e., pol γ), B-family (i.e., pols α, δ and ε) or X-family (i.e., pols β, λ and terminal deoxynucleotidyl transferase), and showed no effect on the activities of fish pol δ, plant pols, prokaryotic pols and other DNA metabolic enzymes, such as calf primase of pol α, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerases I and II, T4 polynucleotide kinase or bovine deoxyribonuclease I. This compound also suppressed the growth of two cultured human cancer cell lines, HCT116 (colon carcinoma cells) and HeLa (cervix carcinoma cells), and UV-treated HeLa cells exhibited lower clonogenic survival in the presence of inhibitor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5. (A) Human cancer cell growth inhibition dose-response curves of 3-O-methyl-funicone (1). Various concentrations (0 to 150 μM) of compound 1 were incubated with human colon carcinoma (HCT116) cells (circle) and human cervix carcinoma (HeLa) cells (square) for 24 h. Rate of cell growth was determined by MTT assay [44] as described in the Experimental section. Data are shown as the means ± SEM of five independent experiments. (B) Clonogenic survival of UV-treated HeLa cells by compound 1. Various concentrations (0 to 100 μM) of compound 1 were incubated with 10 J/m2 UV-treated (closed circle) or untreated (open circle) HeLa cells. After 7 days, the number of colonies in each treatment group was counted. Values are the means ± SEM of two independent experiments.](https://figures.cochat.ai/paper-figures/30e68cff80924f31b725751e59e35d4f/3-o-methylfunicone-a-selective-inhibitor-of-mammalian-y-family-dna-polymerases-figure-5.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The development of drugs interfering with different aspects of the TLS pathway was also attempted with promising results [113,114,115,116]”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [114]
In the citing paper
“These compounds, however, cannot achieve complete TLS inhibition.”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
EUKARYOTIC TRANSLESION SYNTHESIS DNA POLYMERASES: Specificity of Structure and Function
Prakash, S., Johnson, R. E., & Prakash, L. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133250 · Cited by 1,000
Hübscher, U., Maga, G., & Spadari, S. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.090501.150041 · Cited by 691
Bebenek, K., & Kunkel, T. A. (2004) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(04)69005-x · Cited by 258
Interaction of hREV1 with three human Y‐family DNA polymerases
Ohashi, E., Murakumo, Y., Kanjo, N., Akagi, J., Masutani, C., Hanaoka, F., & Ohmori, H. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00747.x · Cited by 256
The many faces of DNA polymerases: Strategies for mutagenesis and for mutational avoidance
Friedberg, E. C., Feaver, W. J., & Gerlach, V. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120152397 · Cited by 222
Fatty acids selectively inhibit eukaryotic DNA polymerase activities in vitro
Mizushina, Y., Tanaka, N., Yagi, H., Kurosawa, T., Onoue, M., Seto, H., Horie, T.-I., Aoyagi, N., Yamaoka, M., Matsukage, A., et al. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00121-2 · Cited by 186
Self-citationThe inhibitory action of fatty acids on DNA polymerase β
Mizushina, Y., Yoshida, S., Matsukage, A., & Sakaguchi, K. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00067-6 · Cited by 163
Self-citationExpression of active rat DNA polymerase .beta. in Escherichia coli
Date, T., Yamaguchi, M., Hirose, F., Nishimoto, Y., Tanihara, K., & Matsukage, A. (1988) · Biochemistry · doi:10.1021/bi00408a048 · Cited by 162
The Mode of Inhibitory Action by Aphidicolin on Eukaryotic DNA Polymerase α
Oguro, M., Suzuki‐Hori, C., Nagano, H., Mano, Y., & Ikegami, S. (1979) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1979.tb13149.x · Cited by 145
Cited by
DNA repair dysregulation from cancer driver to therapeutic target
Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051
Lange, S. S., Takata, K.-I., & Wood, R. D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2998 · Cited by 615
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2011) · Nat. Prod. Rep. · doi:10.1039/c005001f · Cited by 470
DNA damage tolerance: a double-edged sword guarding the genome.
Ghosal, G., & Chen, J. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.04.01 · Cited by 190
Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin
Nicoletti, R., & Trincone, A. (2016) · Marine Drugs · doi:10.3390/md14020037 · Cited by 191
A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy
Wojtaszek, J. L., Chatterjee, N., Najeeb, J., Ramos, A., Lee, M., Bian, K., Xue, J. Y., Fenton, B. A., Park, H., Li, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.028 · Cited by 194
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
Liu, Y., Yang, Q., Xia, G., Huang, H., Li, H., Ma, L., Lu, Y., He, L., Xia, X., & She, Z. (2015) · Journal of Natural Products · doi:10.1021/np500885f · Cited by 98
Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
Yamanaka, K., Chatterjee, N., Hemann, M. T., & Walker, G. C. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006842 · Cited by 87
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics
Korzhnev, D. M., & Hadden, M. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00596 · Cited by 58
Translesion DNA Synthesis in Cancer: Molecular Mechanisms and Therapeutic Opportunities
Zafar, M. K., & Eoff, R. L. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.7b00157 · Cited by 53
Polymerase iota - an odd sibling among Y family polymerases
McIntyre, J. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102753 · Cited by 52
Translesion synthesis inhibitors as a new class of cancer chemotherapeutics
Patel, S. M., Dash, R. C., & Hadden, M. K. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1850692 · Cited by 41
Secondary metabolites from the mangrove sediment-derived fungus Penicillium pinophilum SCAU037
He, F., Li, X., Yu, J., Zhang, X., Nong, X., Chen, G., Zhu, K., Wang, Y., Bao, J., & Zhang, H. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.104177 · Cited by 43
DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target
Ler, A. A. L., & Carty, M. P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.822500 · Cited by 42
Temprine, K., Campbell, N. R., Huang, T. H., Langdon, E. M., Simon-Vermot, T., Mehta, K., Clapp, A., Chipman, M. E., & White, R. M. (2020) · Science Signaling · doi:10.1126/scisignal.aau1453 · Cited by 38
A Comprehensive Strategy to Discover Inhibitors of the Translesion Synthesis DNA Polymerase κ
Yamanaka, K., Dorjsuren, D., Eoff, R. L., Egli, M., Maloney, D. J., Jadhav, A., Simeonov, A., & Lloyd, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045032 · Cited by 35
Inhibitory effects of sulfobacin B on DNA polymerase and inflammation
Mizushina (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000522 · Cited by 31
Ehrlich, M., & Carell, T. (2012) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201201256 · Cited by 27
Mizushina, Y., Zhang, J., Pugliese, A., Kim, S., & Lü, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.031 · Cited by 26
Self-citationBiological and Therapeutic Relevance of Nonreplicative DNA Polymerases to Cancer
Parsons, J. L., Nicolay, N. H., & Sharma, R. A. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4203 · Cited by 26
Targeting Cancer Stem Cells with Defined Compounds and Drugs
Naujokata, C., & Laufer, S. (2013) · Journal of cancer research updates · doi:10.6000/1929-2279.2013.02.01.7 · Cited by 27
Selective Modulation of DNA Polymerase Activity by Fixed‐Conformation Nucleoside Analogues
Eoff, R. L., McGrath, C. E., Maddukuri, L., Salamanca-Pinzon, S. G., Márquez, V. E., Marnett, L. J., Guengerich, F. P., & Egli, M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201003168 · Cited by 24
Ketkar, A. D., Maddukuri, L., Penthala, N. R., Reed, M. R., Zafar, M. K., Crooks, P. A., & Eoff, R. L. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00304 · Cited by 23
Gallo, D., & Brown, G. W. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1651817 · Cited by 23
Leukotriene Biosynthesis Inhibitor MK886 Impedes DNA Polymerase Activity
Ketkar, A. D., Zafar, M. K., Maddukuri, L., Yamanaka, K., Banerjee, S., Egli, M., Choi, J.-Y., Lloyd, R. S., & Eoff, R. L. (2013) · Chemical Research in Toxicology · doi:10.1021/tx300392m · Cited by 20
New Insights into Chemical and Biological Properties of Funicone-like Compounds
Salvatore, M. M., DellaGreca, M., Andolfi, A., & Nicoletti, R. (2022) · Toxins · doi:10.3390/toxins14070466 · Cited by 19
Mizushina, Y., Maeda, J., Irino, Y., Nishida, M., Nishiumi, S., Kondo, Y., Nishio, K., Kuramochi, K., Tsubaki, K., Kuriyama, I., et al. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12021115 · Cited by 18
Self-citationChemical synthesis of funicone analogs
Manzo, E., & Ciavatta, M. L. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.04.010 · Cited by 13
Translesion Synthesis of 1,3‐GTG Cisplatin DNA Lesions
Schneider, S., Reißner, T., Ziv, O., Livneh, Z., & Carell, T. (2010) · ChemBioChem · doi:10.1002/cbic.201000211 · Cited by 13
“One-Pot” Synthesis of γ-Pyrones from Aromatic Ketones/Heteroarenes and Carboxylic Acids
Sun, X., Gong, M., Huang, M., Li, Y., Kim, J. K., Kovalev, V. V., Shokova, É. A., & Wu, Y. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c01924 · Cited by 12
Mizushina, Y., Nishiumi, S., Nishida, M., Yoshida, H., Azuma, T., & Yoshida, M. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1771 · Cited by 10
Self-citationDehydroaltenusin is a specific inhibitor of mammalian DNA polymerase α
Mizushina, Y., Maeda, N., Kuriyama, I., & Yoshida, H. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.619977 · Cited by 8
Self-citationBioactive compounds from marine-derived fungi and their potential applications
Kushveer, J. S., Rashmi, M., & Sarma, V. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821734-4.00014-9 · Cited by 9
Kochnev, I. A., Zavyalova, L. S., Avkhadieva, A. I., Tverdokhlebov, N. A., & Barkov, A. Y. (2024) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2024.110368 · Cited by 3
Sato, S., & Itamochi, H. (2015) · InTech eBooks · doi:10.5772/59513 · Cited by 4
Selective Modulation of DNA Polymerase Activity by Fixed‐Conformation Nucleoside Analogues
Eoff, R. L., McGrath, C. E., Maddukuri, L., Salamanca-Pinzon, S. G., Márquez, V. E., Marnett, L. J., Guengerich, F. P., & Egli, M. (2010) · Angewandte Chemie · doi:10.1002/ange.201003168 · Cited by 2
IMPLICATIONS FOR THERAPY Personalized Therapy of Cancer
Yamanaka, K., & Lloyd, R. (2013) · CRC Press eBooks · doi:10.1201/b14587-12 · Cited by 1
Specificity of damage-bypass DNA polymerases E. coli DinB and human pol κ
Antczak (2017) · Digital Repository Service (Northeastern University) · doi:10.17760/d20260514
Ma, X., Yang, F., Ma, K., Shen, H., Han, J., Wang, K., Yang, Y., Zhu, J., An, R., Wang, Q., et al. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250241
Metadata
- Authors
- Mizushina, Y., Motoshima, H., Yamaguchi, Y., Takeuchi, T., Hirano, K., Sugawara, F., & Yoshida, H.
- Affiliations
- Kobe Gakuin University (JP)
- Tokyo University of Science (JP)
- Nano-bioanalysis Team, Health Technology Research Center, Takamatsu, Kagawa 761-0395 Japan
- Corresponding author
- Mizushina, Yoshiyuki
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2009-11-23
- Volume
- 7
- Issue
- 4
- Pages
- 624-639
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC2810227
- OpenAlex
- W2119902836
- Cited by
- 42
- References
- 46
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2013: 5 · 2012: 5
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Salt Science Research Foundation
- Ministry of Education, Culture, Sports, Science and Technology (19680031, 2006–2010)
- Topics
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Keywords
- Y-family DNA polymerases, DNA polymerase kappa, DNA polymerase eta, DNA polymerase iota, marine fungi, anticancer activity, UV-induced DNA damage, clonogenic survival, HCT116 cells, HeLa cells
- MeSH terms
- Animals, Antineoplastic Agents, Australia, Cattle, DNA Nucleotidylexotransferase, DNA-Directed DNA Polymerase, Drug Screening Assays, Antitumor, Fungi, Humans, IMP Dehydrogenase, Nucleotidyltransferases, Pyrones, Salts, Seawater, Structure-Activity Relationship, Nucleic Acid Synthesis Inhibitors, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.